Multimodal neuroimaging relationships in progressive supranuclear palsy.
Aged
Atrophy
/ diagnostic imaging
Brain
/ diagnostic imaging
Diffusion Tensor Imaging
/ methods
Female
Humans
Image Interpretation, Computer-Assisted
/ methods
Magnetic Resonance Imaging
Male
Middle Aged
Multimodal Imaging
/ methods
Nerve Degeneration
/ diagnostic imaging
Neuroimaging
/ methods
Positron-Emission Tomography
/ methods
Supranuclear Palsy, Progressive
/ diagnostic imaging
White Matter
/ diagnostic imaging
DTI
MRI
Multimodal imaging
PSP
Tau-PET
Journal
Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
27
03
2019
revised:
04
06
2019
accepted:
01
07
2019
pubmed:
8
7
2019
medline:
1
7
2020
entrez:
8
7
2019
Statut:
ppublish
Résumé
Progressive supranuclear palsy is characterized primarily by 4R tau inclusions, atrophy in the brainstem and basal ganglia, and neurodegeneration along the dentatorubrothalamic tract, which are measurable in vivo using flortaucipir PET, T1-weighted MRI, and MRI with diffusion tensor imaging (DTI). However, little is known about how these processes relate to each other. The aim of this study was to investigate multimodal associations between flortaucipir PET uptake, tissue volume loss on structural MRI and white matter tract disruption on DTI. Thirty-four patients with progressive supranuclear palsy and 29 normal controls underwent flortaucipir PET, MRI and DTI. Voxel-wise comparison was performed between patients and controls. Sparse canonical correlations analysis was applied on regional measurements of flortaucipir uptake, tissue volume, fractional anisotropy and mean diffusivity of the PSP population. Pearson's correlation coefficients were assessed across modalities on the regions identified by the sparse canonical correlation analyses. Sparse canonical correlation analyses identified associations between elevated flortaucipir uptake in the cerebellar dentate, red nucleus and subthalamic nucleus and decreased volume in the same regions, and decreased fractional anisotropy and increased mean diffusivity in tracts including the superior cerebellar peduncle, sagittal striatum and posterior corona radiata. Furthermore, decreased fractional anisotropy and increased mean diffusivity in the body of the corpus callosum and anterior and superior corona radiata were related to volume loss in the frontal lobe. Tau uptake measured by flortaucipir PET appears to be related to the neurodegenerative process of progressive supranuclear palsy, including reduced tissue volume and white matter tract degeneration.
Identifiants
pubmed: 31279635
pii: S1353-8020(19)30291-3
doi: 10.1016/j.parkreldis.2019.07.001
pmc: PMC6779505
mid: NIHMS1534604
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
56-61Subventions
Organisme : NIDCD NIH HHS
ID : R01 DC012519
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS089757
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS094684
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.
Références
Acta Neuropathol. 2016 Dec;132(6):931-933
pubmed: 27645292
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Arch Neurol. 2011 Jun;68(6):753-60
pubmed: 21670399
Mov Disord. 2017 Jan;32(1):124-133
pubmed: 27787958
Brain. 2018 Feb 1;141(2):550-567
pubmed: 29293892
Hum Brain Mapp. 2019 Apr 15;40(6):1729-1737
pubmed: 30474903
Mov Disord. 2013 Jul;28(8):1117-24
pubmed: 23568852
J Neurol Sci. 1997 Nov 25;152(2):210-7
pubmed: 9415543
Neuroimage. 2018 Apr 15;170:271-282
pubmed: 28536045
Neuropathology. 2006 Feb;26(1):50-6
pubmed: 16521479
Mov Disord. 2017 Jul;32(7):955-971
pubmed: 28500751
J Neuropathol Exp Neurol. 2000 Jun;59(6):513-24
pubmed: 10850864
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):696-701
pubmed: 29348302
Neuroimage. 2014 Jul 1;94:65-78
pubmed: 24650605
Acta Neuropathol Commun. 2016 Jun 13;4(1):58
pubmed: 27296779
Neuroimage. 2004 Oct;23(2):663-9
pubmed: 15488416
Ann Neurol. 2015 Nov;78(5):787-800
pubmed: 26344059
Ann Neurol. 2017 Oct;82(4):622-634
pubmed: 28980714
Mov Disord. 2011 Aug 1;26(9):1752-5
pubmed: 21500281
Brain. 2017 Mar 1;140(3):781-791
pubmed: 28122879
Parkinsonism Relat Disord. 2011 Sep;17(8):599-605
pubmed: 21665514
J Nucl Med. 2018 Jan;59(1):117-120
pubmed: 28775201
Alzheimers Dement. 2016 Nov;12(11):1116-1124
pubmed: 26892233
Parkinsonism Relat Disord. 2018 Apr;49:81-87
pubmed: 29463454
Mov Disord. 2019 Jan;34(1):105-113
pubmed: 30468693
Parkinsonism Relat Disord. 2018 Mar;48:3-9
pubmed: 29254665
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):457-63
pubmed: 16306152
Neuroimage Clin. 2019;23:101823
pubmed: 31004914
Biostatistics. 2009 Jul;10(3):515-34
pubmed: 19377034
Neuroimage. 2010 Apr 15;50(3):1004-16
pubmed: 20083207
Acta Neuropathol. 2016 Dec;132(6):935-937
pubmed: 27815633